Assessment of frozen glove use in the prevention of docetaxel induced onycholysis and cutaneous reaction. Results of a multicenter case-control study.

Abstract

8003 Background: Onycholysis and skin toxicity occur in about 15% of patients (pts) treated with docetaxel (D). We investigated the efficacy and safety of an Elasto-Gel (Akromed, France) flexible frozen glove (FG) for the prevention of D-induced onycholysis and skin toxicity. METHODS Cancer pts receiving D at 75 mg/m2 (1 hour infusion q3w) alone or in… (More)

Topics

Cite this paper

@article{Scott2004AssessmentOF, title={Assessment of frozen glove use in the prevention of docetaxel induced onycholysis and cutaneous reaction. Results of a multicenter case-control study.}, author={Florian Scott{\'e} and Jean Marc Tourani and E. Afreen Banu and Mich{\"a}el Peyromaure and Arash Jenabian and {\'E}mile L{\'e}vy and K Coquelin and Emmanuelle Magherini and Samuel Marsan and Stephan Oudard}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2004}, volume={22 14_suppl}, pages={8003} }